CONMED Corporation (CNMD): Price and Financial Metrics

CONMED Corporation (CNMD): $101.15

0.27 (-0.27%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

CNMD Price/Volume Stats

Current price $101.15 52-week high $138.47
Prev. close $101.42 52-week low $71.09
Day low $99.95 Volume 364,800
Day high $101.97 Avg. volume 376,752
50-day MA $113.45 Dividend yield 0.79%
200-day MA $109.44 Market Cap 3.11B

CNMD Stock Price Chart Interactive Chart >

CNMD POWR Grades

  • Value is the dimension where CNMD ranks best; there it ranks ahead of 60.62% of US stocks.
  • CNMD's strongest trending metric is Stability; it's been moving up over the last 179 days.
  • CNMD ranks lowest in Sentiment; there it ranks in the 9th percentile.

CNMD Stock Summary

  • CNMD's went public 33.51 years ago, making it older than 85.21% of listed US stocks we're tracking.
  • Price to trailing twelve month operating cash flow for CNMD is currently 89.41, higher than 97.01% of US stocks with positive operating cash flow.
  • In terms of twelve month growth in earnings before interest and taxes, CONMED CORP is reporting a growth rate of -2,840.15%; that's higher than merely 0.48% of US stocks.
  • If you're looking for stocks that are quantitatively similar to CONMED CORP, a group of peers worth examining would be WFRD, DGLY, MARK, DHX, and CDRE.
  • Visit CNMD's SEC page to see the company's official filings. To visit the company's web site, go to www.conmed.com.

CNMD Valuation Summary

  • In comparison to the median Healthcare stock, CNMD's price/earnings ratio is 37.98% higher, now standing at 37.6.
  • CNMD's price/sales ratio has moved up 1.6 over the prior 243 months.

Below are key valuation metrics over time for CNMD.

Stock Date P/S P/B P/E EV/EBIT
CNMD 2023-09-18 2.9 4.3 37.6 68.5
CNMD 2023-09-15 2.9 4.2 37.5 68.3
CNMD 2023-09-14 2.9 4.2 37.5 68.4
CNMD 2023-09-13 2.9 4.2 37.4 68.2
CNMD 2023-09-12 2.9 4.2 37.5 68.4
CNMD 2023-09-11 2.9 4.3 37.9 69.0

CNMD Growth Metrics

    Its 5 year cash and equivalents growth rate is now at -29.86%.
  • Its 4 year cash and equivalents growth rate is now at -29.86%.
  • Its 2 year revenue growth rate is now at 7.32%.
Over the past 15 months, CNMD's revenue has gone up $90,074,000.

The table below shows CNMD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 1,068.575 78.748 -82.722
2022-06-30 1,042.314 74.217 -113.924
2022-03-31 1,020.285 89.754 67.657
2021-12-31 1,010.635 111.77 62.542
2021-09-30 989.493 98.13 62.238
2021-06-30 978.501 111.894 54.14

CNMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CNMD has a Quality Grade of C, ranking ahead of 54.31% of graded US stocks.
  • CNMD's asset turnover comes in at 0.564 -- ranking 77th of 186 Medical Equipment stocks.
  • OSUR, MMSI, and BSX are the stocks whose asset turnover ratios are most correlated with CNMD.

The table below shows CNMD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.564 0.554 0.083
2021-06-30 0.559 0.551 0.086
2021-03-31 0.506 0.533 0.045
2020-12-31 0.495 0.534 0.038
2020-09-30 0.500 0.534 0.041
2020-06-30 0.497 0.532 0.033

CONMED Corporation (CNMD) Company Bio


CONMED Corporation is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The company was founded in 1970 and is based in Utica, New York.


CNMD Latest News Stream


Event/Time News Detail
Loading, please wait...

CNMD Latest Social Stream


Loading social stream, please wait...

View Full CNMD Social Stream

Latest CNMD News From Around the Web

Below are the latest news stories about CONMED CORP that investors may wish to consider to help them evaluate CNMD as an investment opportunity.

Insider Sell: President AS and AET Peters Stanley W III Sells 2000 Shares of Conmed Corp

On September 13, 2023, Peters Stanley W III, President AS and AET of Conmed Corp (NYSE:CNMD), sold 2,000 shares of the company.

Yahoo | September 16, 2023

CONMED Corporation to Participate in a Virtual Fireside Chat at the CL King Best Ideas Conference

LARGO, Fla., September 05, 2023--CONMED Corporation (NYSE: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the CL King 21st Annual Best Ideas Conference at 10:15 a.m. ET on Monday, September 18, 2023.

Yahoo | September 5, 2023

Is a Beat Likely for Cooper Companies (COO) in Q3 Earnings?

Cooper Companies' (COO) fiscal third-quarter results are likely to reflect segmental strength.

Yahoo | August 28, 2023

Is a Beat Likely for Patterson Companies (PDCO) in Q1 Earnings?

Patterson Companies' (PDCO) fiscal first-quarter results are likely to reflect an improvement at both Dental and Animal Health segments.

Yahoo | August 25, 2023

CONMED Corporation to Participate in a Fireside Chat at the Wells Fargo Healthcare Conference

LARGO, Fla., August 24, 2023--CONMED Corporation (NYSE: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Wells Fargo Healthcare Conference at 2:15 p.m. ET on Thursday, September 7, 2023.

Yahoo | August 24, 2023

Read More 'CNMD' Stories Here

CNMD Price Returns

1-mo -6.13%
3-mo -22.92%
6-mo 3.12%
1-year 24.16%
3-year 41.01%
5-year 32.94%
YTD 14.75%
2022 -36.98%
2021 27.35%
2020 1.16%
2019 75.71%
2018 27.39%

CNMD Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full CNMD Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!